Skip to main content

Site notifications

AusPAR: Dapagliflozin

Australian Public Assessment Report
Device/Product Name
Forxiga
Active ingredients
Dapagliflozin
AusPAR Date
Published
Submission Number
PM-2019-05370-1-3
Submission Type
Extension of indications
Decision
Approved

Help us improve the Therapeutic Goods Administration site